Woodward Company Profile

✉ Email this page to a colleague

WOODWARD has thirteen approved drugs.

There is one US patent protecting WOODWARD drugs.

There are twenty-four patent family members on WOODWARD drugs in fourteen countries and twelve supplementary protection certificates in five countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Woodward Specl	DECA-DURABOLIN	nandrolone decanoate	INJECTABLE;INJECTION	013132-002	Jun 12, 1986		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Woodward	LUNESTA	eszopiclone	TABLET;ORAL	021476-002	Dec 15, 2004	AB	RX	Yes	No		⤷ Try a Trial				⤷ Try a Trial
Woodward	COREG CR	carvedilol phosphate	CAPSULE, EXTENDED RELEASE;ORAL	022012-003	Oct 20, 2006	AB	RX	Yes	Yes	8,101,209*PED	⤷ Try a Trial			Y	⤷ Try a Trial
Woodward	DAPIPRAZOLE HYDROCHLORIDE	dapiprazole hydrochloride	SOLUTION/DROPS;OPHTHALMIC	204902-001	May 30, 2019		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Woodward	AVANDIA	rosiglitazone maleate	TABLET;ORAL	021071-003	May 25, 1999		DISCN	Yes	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Woodward	COREG	carvedilol	TABLET;ORAL	020297-001	Sep 14, 1995	RE40000*PED	⤷ Try a Trial
Woodward	ACIPHEX	rabeprazole sodium	TABLET, DELAYED RELEASE;ORAL	020973-002	Aug 19, 1999	5,035,899	⤷ Try a Trial
Woodward	COREG	carvedilol	TABLET;ORAL	020297-002	Sep 14, 1995	5,902,821*PED	⤷ Try a Trial
Woodward	COREG	carvedilol	TABLET;ORAL	020297-003	Sep 14, 1995	4,503,067*PED	⤷ Try a Trial
Woodward	COREG CR	carvedilol phosphate	CAPSULE, EXTENDED RELEASE;ORAL	022012-004	Oct 20, 2006	7,268,156*PED	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Extended-release Capsules	40 mg	➤ Subscribe	2007-12-21
➤ Subscribe	Capsule	0.5 mg/0.4 mg	➤ Subscribe	2010-10-26
➤ Subscribe	Tablets	1 mg, 2 mg and 3 mg	➤ Subscribe	2008-12-15
➤ Subscribe	Extended-release Capsules	10 mg and 20 mg	➤ Subscribe	2008-03-18
➤ Subscribe	Extended-release Capsules	80 mg	➤ Subscribe	2007-11-19
➤ Subscribe	Capsules	1 g	➤ Subscribe	2008-11-10

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0268956	1999C0030	Belgium	⤷ Try a Trial	PRODUCT NAME: RABEPRAZOLE SODIUM; NAT. REGISTRATION NO/DATE: 5532 IE 1 F 3 19990201; FIRST REGISTRATION: GB 10555/0010 19980508
0181055	96C0001	Belgium	⤷ Try a Trial	PRODUCT NAME: MIVACURIUM CHLORID.= MIVACURIUM (+5% OVERDOSERING); NAT REG.: 251 IS 152 F 12 19951114; FIRST REG.: GB 0003/0325 19921208
0658161	01C0002	France	⤷ Try a Trial	PRODUCT NAME: MALEATE DE ROSIGLITAZONE OU L UN DE SES ISOMERES OU UNE DE SES FORMES TAUTOMERES ET/OU UN DE SES SOLVATES PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: EU/1/00/137/001 DU 20000711; REGISTRATION NO/DATE AT EEC: IKS NÃ¸ 55 176 DU 19990929
0719278	03C0030	France	⤷ Try a Trial	PRODUCT NAME: DUTASTERIDE; NAT. REGISTRATION NO/DATE: NL 28 131 20030327; FIRST REGISTRATION: SE - 17 871 20020719
0658161	39/2000	Austria	⤷ Try a Trial	PRODUCT NAME: ROSIGLITAZONE MALEAT; NAT. REGISTRATION NO/DATE: EU/1/00/137/001 - EU/1/00/137/012 20000711; FIRST REGISTRATION: LI 55176 19990929
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.